Diabetes drugs are one of the costliest for health plans, and a recent KFF report showed that they accounted for up 7 out of 22 top drugs whose prices outpaced inflation. How are health plans responding? Each day, more health plans are looking for innovative solutions (outside of traditional diabetes management) to combat the insulin cost crisis. We were honored to have the Chief Pharmacy Officer at SCAN Health join us and share how they’re tackling insulin and Rx affordability for their members, and specifically, reversing type 2 diabetes in their population.
- Sharon Jhawar (Chief Pharmacy Officer, SCAN Health)
- Robert Ratner (Chief Medical Officer, Virta Health)
- Cybele Bjorklund (Senior Vice President of Policy, Virta Health)